L, G., L, L., Y, G., B, Z., & S, Z. (2026). Glycolytic reprogramming in endometriosis: Molecular mechanisms, immune modulation, and non-hormonal therapeutic opportunities. BMC women's health, 26(1), . https://doi.org/10.1186/s12905-026-04570-4
Chicago Style (17th ed.) CitationL, Guo, Liu L, Geng Y, Zhang B, and Zhao S. "Glycolytic Reprogramming in Endometriosis: Molecular Mechanisms, Immune Modulation, and Non-hormonal Therapeutic Opportunities." BMC Women's Health 26, no. 1 (2026). https://doi.org/10.1186/s12905-026-04570-4.
MLA (9th ed.) CitationL, Guo, et al. "Glycolytic Reprogramming in Endometriosis: Molecular Mechanisms, Immune Modulation, and Non-hormonal Therapeutic Opportunities." BMC Women's Health, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12905-026-04570-4.